Change in lipase, protease, amylase and lysosomal activity, metabolomic, proteomic or peptidic analysis on saliva samples at enrolment, and at months 3, 6, 9 and 12 at enrolment, and at months 3, 6, 9 and 12 [clinicaltrials_resource:a585e4d37ed0b1138c992dd5494a7542]
Oral disorder children aged 2 to 15 years
clinicaltrials_vocabulary:secondary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:secondary-outcome]
Change in lipase, protease, amylase and lysosomal activity, metabolomic, proteomic or peptidic analysis on saliva samples at enrolment, and at months 3, 6, 9 and 12 at enrolment, and at months 3, 6, 9 and 12 [clinicaltrials_resource:a585e4d37ed0b1138c992dd5494a7542]
Oral disorder children aged 2 to 15 years
Bio2RDF identifier
a585e4d37ed0b1138c992dd5494a7542
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:a585e4d37ed0b1138c992dd5494a7542
measure [clinicaltrials_vocabulary:measure]
Change in lipase, protease, am ...... , and at months 3, 6, 9 and 12
time frame [clinicaltrials_vocabulary:time-frame]
at enrolment, and at months 3, 6, 9 and 12
description
Oral disorder children aged 2 to 15 years
identifier
clinicaltrials_resource:a585e4d37ed0b1138c992dd5494a7542
title
Change in lipase, protease, am ...... , and at months 3, 6, 9 and 12
@en
type
label
Change in lipase, protease, am ...... 5e4d37ed0b1138c992dd5494a7542]
@en